Q2 2024 Azenta Inc Earnings Call Transcript
Key Points
- Azenta Inc reported a solid Q2 with revenue of $159 million, marking a 7% year-over-year increase.
- The company achieved organic growth in all three business segments despite a downmarket, highlighting strong operational execution.
- Significant cost reductions and operational efficiencies have been implemented, reducing annual expenses by more than $25 million.
- Azenta Inc is on track with its Ascend 2026 plan aiming to lift EBITDA to high teens by 2026, with innovative products launched in each segment.
- The company's Sample Management Solutions (SMS) segment saw a revenue increase of 3% year-over-year, with strategic investments yielding positive results.
- CEO Stephen Schwartz announced his retirement, initiating a search for a successor which could bring uncertainty during the transition period.
- The B Medical segment faces challenges with unpredictable timing of purchase orders, impacting revenue forecasting accuracy.
- Revenue from the Life Sciences Services market continues to face headwinds, although Multiomics segment revenue increased slightly.
- The company recorded a $111 million noncash goodwill impairment charge related to the B Medical segment.
- Adjustments to B Medical revenue expectations were made, lowering the forecast for the fourth quarter to approximately $25 million to $30 million.
Greetings, and welcome to the Azenta Second Quarter 2024 Financial Results. (Operator Instructions) As a reminder, this conference is being recorded, Wednesday, March 8, 2024.
I will now turn the conference over to Yvonne Perron, Vice President, FP&A and Investor Relations.
Thank you, operator, and good afternoon to everyone on the line today. We would like to welcome you to our earnings conference call for the second quarter of fiscal year 2024. Our second quarter earnings press release was issued after the close of the market today, and is available on our Investor Relations website located at investors.azenta.com in addition to the supplementary PowerPoint slides that will be used during the prepared remarks today. I would like to remind everyone that during the course of the call, we will be making a number of forward-looking statements within the meaning of the Private Litigation Securities Act of 1995. There are many factors that may cause actual financial results or other events to differ from those identified in such forward-looking
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
